Chris Dunk

Chris Dunk serves as the Director of Clinical Study Management at Alimentiv since August 2020, overseeing study governance and managing a dedicated team of clinical trial professionals. Previously, Dunk held roles including Director of the Therapeutic Area Centre of Excellence, focusing on operational expertise for diseases such as eosinophilic esophagitis and celiac disease. With extensive experience in clinical development at companies including Atlantic Healthcare plc and Gregory Fryer Associates, Dunk has successfully managed Phase 1-3 clinical studies, regulatory strategy, and project planning. Dunk's career began at Glaxo Pharmaceuticals, progressing through various roles in clinical operations and project management within the biotechnology and pharmaceutical sectors. Dunk holds a PhD in Physiology and a BSc in Biological Sciences from the University of Leicester.